Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span - PubMed (original) (raw)

. 2009 Oct;64(10):1039-44.

doi: 10.1093/gerona/glp091. Epub 2009 Jul 8.

Affiliations

• PMID: 19587105
• DOI: 10.1093/gerona/glp091

Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span

Michael O Thorner. J Gerontol A Biol Sci Med Sci. 2009 Oct.

Abstract

Despite the fact that growth hormone (GH) has not been approved for antiaging purposes, its use for this indication is widespread and increasing. The Growth Hormone Research Society (GRS) convened an international workshop to critically review and debate the available evidence related to the use of GH in the older adults and the relationship between the GH/insulin-like growth factor I (IGF-I) axis and the aging process. This statement presents the conclusions reached and gives recommendations for future studies in this research field regarding the use of GH and growth hormone secretagogues (GHS) for promoting health span. The participants concluded that, until future clinical research in this area is conducted, in particular carefully designed, long-term studies, using validated outcome parameters, the clinical use of GH or GHS in older adults, alone or in combination with testosterone, cannot be recommended. In addition, future basic studies in model systems, to continue to unravel GH/IGF-I effects related to human life span and health span, were advocated.

PubMed Disclaimer

Similar articles

• Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
  Lee KO, Liao L, Mukherjee JJ. Lee KO, et al. Mech Ageing Dev. 2004 Apr;125(4):291-5. doi: 10.1016/j.mad.2004.01.005. Mech Ageing Dev. 2004. PMID: 15063105 Review.
• Growth hormone secretagogues: prospects and potential pitfalls.
  Smith RG, Sun Y, Betancourt L, Asnicar M. Smith RG, et al. Best Pract Res Clin Endocrinol Metab. 2004 Sep;18(3):333-47. doi: 10.1016/j.beem.2004.04.001. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 15261841 Review.
• Update on new therapeutic options for the somatopause.
  Ceda GP, Dall'Aglio E, Morganti S, Denti L, Maggio M, Lauretani F, Andrea A, Ceresini G, Cattabiani C, Valenti G. Ceda GP, et al. Acta Biomed. 2010;81 Suppl 1:67-72. Acta Biomed. 2010. PMID: 20518193 Review.
• Somatopause reflects age-related changes in the neural control of GH/IGF-I axis.
  Giordano R, Lanfranco F, Bo M, Pellegrino M, Picu A, Baldi M, Balbo M, Bonelli L, Grottoli S, Ghigo E, Arvat E. Giordano R, et al. J Endocrinol Invest. 2005;28(3 Suppl):94-8. J Endocrinol Invest. 2005. PMID: 16042366 Review.
• Genetic suppression of GH-IGF-1 activity, combined with lifelong caloric restriction, prevents age-related renal damage and prolongs the life span in rats.
  Zha Y, Taguchi T, Nazneen A, Shimokawa I, Higami Y, Razzaque MS. Zha Y, et al. Am J Nephrol. 2008;28(5):755-64. doi: 10.1159/000128607. Epub 2008 Apr 24. Am J Nephrol. 2008. PMID: 18434714

Cited by

• Trajectories of IGF-I Predict Mortality in Older Adults: The Cardiovascular Health Study.
  Sanders JL, Guo W, O'Meara ES, Kaplan RC, Pollak MN, Bartz TM, Newman AB, Fried LP, Cappola AR. Sanders JL, et al. J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):953-959. doi: 10.1093/gerona/glx143. J Gerontol A Biol Sci Med Sci. 2018. PMID: 28977343 Free PMC article.
• Update on GH therapy in adults.
  Boguszewski CL. Boguszewski CL. F1000Res. 2017 Nov 16;6:2017. doi: 10.12688/f1000research.12057.1. eCollection 2017. F1000Res. 2017. PMID: 29225782 Free PMC article. Review.
• The slow-aging growth hormone receptor/binding protein gene-disrupted (GHR-KO) mouse is protected from aging-resultant neuromusculoskeletal frailty.
  Arum O, Rickman DJ, Kopchick JJ, Bartke A. Arum O, et al. Age (Dordr). 2014 Feb;36(1):117-27. doi: 10.1007/s11357-013-9551-x. Epub 2013 Jul 4. Age (Dordr). 2014. PMID: 23824747 Free PMC article.
• [Growth hormone therapy in adult patients: a review].
  Kann PH. Kann PH. Wien Klin Wochenschr. 2011 May;123(9-10):259-67. doi: 10.1007/s00508-011-1574-7. Epub 2011 May 18. Wien Klin Wochenschr. 2011. PMID: 21590321 Review. German.
• The ghrelin axis in disease: potential therapeutic indications.
  Nass R, Gaylinn BD, Thorner MO. Nass R, et al. Mol Cell Endocrinol. 2011 Jun 20;340(1):106-10. doi: 10.1016/j.mce.2011.02.010. Epub 2011 Feb 25. Mol Cell Endocrinol. 2011. PMID: 21356273 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems